Abstract
BackgroundMEM-288 is a conditionally replicative oncolytic adenovirus expressing human IFNβ and a recombinant membrane-stable form of CD40L (MEM40). Preclinical studies show MEM-288 induces robust dendritic cell (DC)-mediated systemic T-cell responses...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have